Skip to Content


In the US, Canagliflozin (canagliflozin systemic) is a member of the drug class SGLT-2 inhibitors and is used to treat Diabetes, Type 2.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Oral antidiabetic agent: sodium-glucose co-transporter 2 (SGLT2) inhibitor

Chemical Name

(1S)-1,5-anhydro-1-C-(3-{[5-(4-fluorophenyl)tiophen-2-yl]metyl}-4-metylphenyl)-D-glucitol (WHO)

Foreign Names

  • Canagliflozinum (Latin)
  • Canagliflozin (German)
  • Canagliflozine (French)
  • Canagliflozina (Spanish)

Generic Names

  • UNII-6S49DGR869 (IS)
  • Canagliflozin (OS: USAN)
  • Canagliflozin Hydrate (OS: JAN)
  • JNJ-24831754-ZAE (IS)
  • JNJ-28431754 (IS)
  • JNJ-28431754-AAA (IS)
  • TA-7284 (IS)
  • UNII-0SAC974Z85 (IS)

Brand Names

  • Invokamet (Canagliflozin and Metformin hydrochloride)
    Janssen Pharma, United States
  • Invokana
    Janssen, Canada; Janssen, Croatia (Hrvatska); Janssen, Romania; Janssen, Singapore; Janssen Pharma, United States; Janssen-Cilag, Belgium; Janssen-Cilag, Denmark; Janssen-Cilag, Poland; Janssen-Cilag International, Austria; Janssen-Cilag International NV, Slovenia
  • Vokanamet (Canagliflozin and Metformin)
    Janssen, Slovakia; Janssen-Cilag, Denmark; Janssen-Cilag, Greece; Janssen-Cilag, Poland; Janssen-Cilag International NV, Slovenia; Johnson & Johnson, Croatia (Hrvatska)
  • Invokana
    Janssen, Chile; Janssen, Ireland; Janssen, Sweden; Janssen-Cilag, Switzerland; Janssen-Cilag, United Kingdom; Janssen-Cilag, Mexico; Janssen-Cilag International NV, Germany
  • Vokanamet (Canagliflozin and Metformin)
    Janssen-Cilag, Switzerland; Janssen-Cilag, United Kingdom; Janssen-Cilag International, Austria


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.